Search for: "PLIVA, Inc. v. Mensing" Results 101 - 120 of 230
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2012, 4:17 am by Max Kennerly, Esq.
Like with prescription drugs, the judicial activists on the Supreme Court have bent over backwards to shield medical device manufacturers from any responsibility for their actions, frequently twisting the words of Congress — sometimes outright inventing Congressional statutes that don’t exist, like in PLIVA, Inc. v. [read post]
7 Jun 2012, 2:40 pm by Bexis
Levine, 555 U.S. 555 (2009), before being consigned to 4-4 limbo in PLIVA, Inc. [read post]
6 Jun 2012, 5:35 am by Bexis
  However, the plaintiff faced the same obstacle that proved fatal to the generic drug plaintiffs in PLIVA v. [read post]
30 May 2012, 12:34 pm by Bethany Turke, Associate
Last month, I highlighted the mounting pressure to remedy the inconsistencies and inequities resulting from the Supreme Court’s decision in PLIVA, Inc. v. [read post]
30 May 2012, 8:28 am by Michelle Yeary
            It has been almost one year since the Supreme Court decided PLIVA v. [read post]
28 May 2012, 3:30 am
Once the Supreme Court ruled that generic drug companies can’t be held liable in failure to warn lawsuits in Pliva v. [read post]
23 May 2012, 2:38 pm by Jeff Klein
A number of our previous blog posts (here, here, and here) discussed the Supreme Court’s decision in Pliva v. [read post]
21 May 2012, 9:16 am by kgwlegal
Supreme Court (PLIVA, INC., ET AL. v. [read post]
11 May 2012, 8:28 am by Joshua Matz
Levine and PLIVA Inc. v. [read post]
8 May 2012, 5:59 pm by FDABlog HPM
Mutual Pharmaceutical Co., which our friends over at the Drug and Device Law Blog commented on as making no sense (“while a simple warning claim involving a generic drug is indisputably preempted under PLIVA, Inc. v. [read post]
7 May 2012, 5:00 am by Bexis
May 2, 2012), was more or less a crie de coeur over what we saw as an essentially absurd result:  that while a simple warning claim involving a generic drug is indisputably preempted under PLIVA, Inc. v. [read post]
16 Apr 2012, 1:37 pm by Max Kennerly, Esq.
A slim 5-4 majority of the Supreme Court disappointingly killed the vast majority of generic drug liability last year with PLIVA, Inc. v. [read post]
10 Apr 2012, 2:33 pm by Carlee Hobbs Toth
The Sixth Circuit will soon have a chance to consider the extent of the Supreme Court’s decision in PLIVA, Inc. v. [read post]
10 Apr 2012, 2:33 pm by Carlee Hobbs Toth
The Sixth Circuit will soon have a chance to consider the extent of the Supreme Court’s decision in PLIVA, Inc. v. [read post]